In 2024, the market generated USD 1.6 trillion in revenue, reinforcing the pharmaceutical industry's heavy reliance on drug formulation. Among various formulations, oral drugs continue to dominate ...
This article is authored by Saransh Chaudhary, president, Global Critical Care, Venus Remedies Ltd and CEO, Venus Medicine ...
VANCOUVER - InMed Pharmaceuticals Inc. (NASDAQ: INM), a small-cap biotech company with a market capitalization of $2.21 million, has announced the selection of an intravitreal (IVT) formulation, ...
India's pharmaceutical sector is witnessing remarkable growth, almost achieving its export target before FY25. Drug ...
The NDA is supported by data from a clinical trial that compared the absorption and efficacy of the nasal treatment with oral and IV bumetanide in 68 healthy adults.
INM-089 IVT formulation selected for continued developmentDemonstrated successful delivery at doses up to 10 times the ...
Rheumatoid arthritis (RA) is an autoimmune disorder affecting millions worldwide, causing chronic inflammation, debilitating ...
Bajaj Health has also extended the offer for Pimavanserin to several leading pharma companies to ensure availability in ...
formulation, INM-089, for further development in its drug pipeline aimed at treating dry age-related macular degeneration (AMD (NASDAQ:AMD)), a condition with limited treatment options.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback